Study uncovers the structure of 1 adrenergic G-protein-coupled receptor (GPCR) (27 Jun 2008) Structure of important drug target elucidated using Heptares' StaR(TM) technology
Heptares Therapeutics Ltd, the drug discovery company focused on the design and development of novel drugs based on G-protein-coupled receptors (GPCRs), is very pleased to announce that one of its founder's key research studies has been...
Galantos Pharma Receives Research Grant (29 May 2008) Expansion of technology platform for the optimization of compounds targeting nicotinic acetylcholine receptors with subunit specificity and selectivity against muscarinic acetylcholine receptors", said Dr... acetylcholine receptors in general (nAChRs) and a subtype-specific APL targeting...
Data suggests promising overall survival and progression-free survival with VARGATEF (BIBF 1120) (29 Apr 2008) Latest phase II data for Boehringer Ingelheim's new cancer drug in development inhibitor that simultaneously inhibits vascular endothelial growth factor receptors (VEGFRs), platelet-derived growth factor receptors (PDGFRs) and fibroblast growth factor receptors (FGFRs)1 - all of which are crucially involved...
Novel method to reveal drug targets (25 Feb 2008) Interactions between proteins studied on a global scale cell surface receptors is often the initiating event during infections. Because...
Labopharm Reports Positive Results for Phase III Study on Once-daily Trazodone (12 Feb 2008) Study Achieves Primary Efficacy Endpoint and Demonstrates Improved Quality of Sleep three mechanisms: the activation of neuronal serotonin receptors... by activation of histamine receptors and initiation and restoration of deep sleep...
Top
